$AEHR

ENGINEER ADIL sold $2.0M of AEHR

ENGINEER ADIL (Chief Operating Officer) sold 15,000 shares of AEHR TEST SYSTEMS (AEHR) at an average of $131.02 ($130.95–$131.10, $1.97M total) across 2 trades on 2026-08-12.

Original reporting
SEC EDGAR · ENGINEER ADIL
Published Aug 13, 2026, 9:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 10:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this disclosure alone does not provide new information about AEHR’s revenue, margins, product pipeline, or guidance.

02

Market read

A newly filed insider sale at AEHR at about $131/share may cause brief sentiment noise, but it is not a fundamental catalyst.

03

What to watch

Insider sales can be driven by diversification, taxes, or personal liquidity needs; the filing does not state intent or whether other holdings/compensation offset the sale.

Relevance 6/10Novelty 4/10Timing: filed after-hours on 2026-08-13, covering trades dated 2026-08-12

Background

The article is a SEC Form 4 insider transaction disclosure for AEHR, filed by its COO.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

AEHR COO ENGINEER ADIL sold about 15,000 shares in open-market transactions at roughly $131/share, per a newly filed Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing discloses the sale size, price range, and that it was not under a pre-arranged 10b5-1 plan, but it provides no new AEHR-specific business or guidance information.

Market effects

Minimal. Insider selling at a single small-cap does not materially reset sector expectations without accompanying fundamentals.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted as a stronger signal than typical routine sales, potentially increasing near-term downside risk if traders treat it as confidence erosion.

Key entities

  • AEHR

    AEHR Test Systems, the company whose insider transaction was reported.

  • ENGINEER ADIL

    Chief Operating Officer who sold shares via open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRMed

AEHR Stock Rides AI Order Wave Amid Volatility

Aehr Test Systems (AEHR) stock rose 13.28% following strong earnings and a positive outlook for semiconductor test demand. The company reported $50M in revenue, $18.8M in quarterly revenue, and a net income of $1.39M. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI production. The stock has shown volatility, with a recent drop of 9.5-10.5% in a single session. Insiders have sold shares but maintain significant holdings. AEHR is actively presenting a

$AEHRHigh

AEHR Stock Rallies As AI Orders And Wall Street Support Build

Aehr Test Systems (AEHR) stock rose 11.71% due to strong AI-related demand. The company reported $18.8M in revenue with a 35.3% gross margin. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI chip production. The company has a strong balance sheet and a $22M follow-on order from a major customer.

$AEHRHigh

AEHR Stock Rallies As AI Test Orders And Wall Street Support Grow

Aehr Test Systems (NASDAQ: AEHR) stock rose 11.73% on growing AI test demand. The company secured a $22M follow-on order for AI chip testing equipment. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's unique position in AI production testing. The stock has high volatility, with a strong balance sheet but negative EBIT margins.